Percentage of adult patients (>18 years old) diagnosed with Actinic Keratosis (AK) whose healthcare provider has recorded the following information in the patient’s medical record 1) documentation of the number or range of AKs, 2) location(s) of AK, 3) documentation of prior squamous cell carcinoma, or prior keratinocyte carcinomas and types if known, 4) age, 5) gender, and 6) immunosuppression and have engaged in bi-directional communication with the patient regarding the risk of malignant transformation and a discussion of at least two options for managing AK.